Little is known regarding the role of Toll-like receptors (TLRs) in regulating protein-and polysaccharidespecific immunoglobulin (Ig) isotype production in response to an in vivo challenge with an extracellular bacterium. In this report we demonstrate that MyD88 
Adaptive immunity to extracellular bacteria is largely conferred by antibody. Antibodies specific for both bacterial polysaccharide and protein antigens have been shown to protect the host from infection with otherwise-lethal Streptococcus pneumoniae strains (3) . Distinct immunoglobulin (Ig) isotypes possess overlapping as well as unique effector functions on the basis of the particular Fc region expressed (45) . Thus, the pattern of Ig isotypes elicited during a bacterial infection, in addition to the epitope specificity and affinity of the Ig, might impact on the level of protection afforded by such an antibody. IgG isotypes such as IgG3, IgG2b, and IgG2a, which are associated with Th1 (gamma interferon [IFN-␥]-dominant) immune responses (13, 44, 46) , are particularly effective at mediating complement fixation and both complement-and Fcmediated bacterial opsonophagocytosis. In contrast, IgG1 elicited during Th2 (interleukin-4 [IL-4]-dominant) immune responses may serve a role in neutralizing pathogenic proteins without inducing complement activation and inflammation (45) .
Inflammatory cytokines, as well as chemokines, play a key role in innate as well as adaptive host defense against pathogens. Innate immunity, including early cytokine release, is initiated upon recognition of conserved pathogen-associated molecular patterns by various host cells expressing pattern recognition receptors (33) . The major pattern recognition receptors in mammalian species are the Toll-like receptor (TLR) family of proteins (2, 42) . These proteins share a common cytoplasmic domain with each other, and with the IL-1 and IL-18 receptors, called the Toll-ILRs. Activated Toll-ILRs mediate the eventual translocation of NF-B and AP-1 into the nucleus via one or a number of distinct adaptor proteins, most critically MyD88, with resultant transcriptional activation of numerous proinflammatory cytokine and chemokine-chemokine receptor genes (19, 48) . At present, 11 different TLRs (TLR1 to -11) have been reported, showing distinct specificities for microbial and even host ligands and utilizing different combinations of adaptor proteins (2, 9, 57) .
The requirement for TLR2 for signaling in response to peptidoglycan, lipoteichoic acid, and lipoproteins (43) has suggested a dominant role for TLR2 in the induction of innate responses to gram-positive bacteria. Indeed, a key role for TLR2 in mediating innate immunity, including cytokine induction in response to a variety of gram-positive bacteria, including S. pneumoniae, has been demonstrated (11, 15, 23, 36, 43, 49) . Nevertheless, TLRs other than TLR2 may play a role in responses to gram-positive bacteria. Thus, MyD88
Ϫ/Ϫ mice showed greater lethality and a more profound defect in macrophage cytokine production in response to Staphylococcus aureus relative to that in TLR2 Ϫ/Ϫ mice (49) . It was recently shown that although TLR2 Ϫ/Ϫ mice are more susceptible to experimental S. pneumoniae meningitis, a substantial part of the inflammatory response was TLR2 independent (23) . Additionally, TLR2
Ϫ/Ϫ mice inoculated intranasally with live S. pneumoniae displayed only a modestly reduced inflammatory response in the lungs and normal host immunity relative to that in wild-type mice, despite defective cytokine production from freshly isolated TLR2 Ϫ/Ϫ alveolar macrophages (22) . Less is known regarding the role of TLRs in shaping the adaptive humoral response to an intact pathogen. Injection of mice with purified antigens in adjuvant demonstrated a role for MyD88 in mediating an antigen-specific type 1, but not type 2, in vivo IgG isotype response (42) . More recently, a normal pathogenspecific IgG isotype response to Borrelia burgdorferi was observed in TLR2
Ϫ/Ϫ mice, although this was associated with a higher burden of pathogen (54) . However, MyD88
Ϫ/Ϫ mice infected with B. burgdorferi demonstrated elevated B. burgdorferi-specific IgM and IgG1 responses, but diminished type 1 antibodies (IgG2a, IgG2b, and IgG3) (27) . Similarly, MyD88
Ϫ/Ϫ mice exhibited reduced leishmania-specific IgG2a, and elevated IgG1, in response to infection with Leishmania major (8) . Finally, a recent report demonstrated a role for endogenous TLR2 in stimulating an Ig response to a Haemophilus influenzae type b-outer membrane protein complex (OMPC) glycoconjugate vaccine that was specific for both the H. influenzae capsular polysaccharide and the OMPC protein (26) .
We earlier demonstrated that challenge of wild-type mice with intact S. pneumoniae, a gram-positive extracellular bacterium, rapidly induces (by 2 to 6 h) a number of proinflammatory cytokines in the spleen (20) . We further demonstrated that the endogenous release of tumor necrosis factor alpha (TNF-␣), IL-6, and IFN-␥ independently stimulated both IgG antiprotein and antipolysaccharide responses of various isotypes following S. pneumoniae immunization. Additionally, both IgG antiprotein and IgG antipolysaccharide responses to S. pneumoniae were dependent on T-cell receptor ␣/␤ ϩ CD4 ϩ T cells (21, 55) , B7-dependent costimulation (55, 56) , and dendritic cells (6, 7) . Direct TLR signaling, including the subsequent release of cytokines, induces dendritic cells to migrate to secondary lymphoid organs, upregulate T-cell costimulatory molecules, including B7, and release IL-12, thus leading to the priming of CD4 ϩ T cells for type 1 immunity. In this regard, we postulated that TLRs would play an important role in the in vivo antiprotein and antipolysaccharide Ig isotype response to intact S. pneumoniae. In this report, we demonstrate a MyD88-dependent pathway for innate protection against challenge with S. pneumoniae which is largely independent of TLR2 but, surprisingly, we observed that both the protein-and polysaccharide-specific type 1 IgG isotype response is largely TLR2 dependent. These data are of particular interest in light of earlier contrasting reports suggesting that TLR2 stimulation favors type 2 responses (10, 39, 40) .
MATERIALS AND METHODS

Mice. TLR2
Ϫ/Ϫ mice (129B6 background) (47) and MyD88 Ϫ/Ϫ mice (C57BL/6 background) (1) were obtained originally from S. Akira (Osaka University, Osaka, Japan) and were bred in our facility. 129B6 mice were obtained from The Jackson Laboratory (Bar Harbor, Maine). C57BL/6 mice were obtained from the National Cancer Institute (Frederick, Md.). All mice were typically used between 6 and 10 weeks of age. These studies were conducted in accordance with the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, National Research Council, revised 1996 (34a), and were approved by the Uniformed Services University of the Health Sciences Institutional Animal Use and Care Committee.
Genotyping. (i) TLR2
؊/؊ mice. The following primers were used for genotyping TLR2 Ϫ/Ϫ mice: primer A, 5Ј GTT TAG TGC CTG TAT CCA GTC AGT GCG 3Ј; B, 5Ј AAT GGG TCA AGT CAA CAC TTC TCT GGC 3Ј; and C, 5Ј ATC GCC TTC TAT CGC CTT CTT GAC GAG 3Ј. For PCR, we used 200 ng of DNA and applied the following conditions: 94°C for 1 min; 35 cycles of 94°C for 30 s, 67°C for 30 s, and 72°C for 1 min; and 72°C for 10 min. Products were separated on a 1% agarose gel. For detection of the mutated allele, we used primers B and C. For the wild-type allele, we used primers A and B. The amplified products were both about 1,200 bp.
(ii) MyD88 ؊/؊ mice. For genotyping of MyD88 Ϫ/Ϫ mice, three primers were mixed together: left, 5Ј TGG CAT GCC TCC ATC ATA GTT AAC C 3Ј; right, 5Ј GTC AGA AAC AAC CAC CAC CAT GC 3Ј; and Neo, 5Ј ATC GCC TTC TAT CGC CTT CTT GAC G 3Ј. For PCR, we used 200 ng of DNA and applied the following conditions: 94°C for 3 min; 35 cycles of 94°C for 40 s, 65°C for 40 s, and 72°C for 50 s; and 72°C for 10 min. Products were separated on a 2% Nusieve agarose gel. The wild-type gene gave a product 563 bp long. The size of the product in knockout mice was about 640 bp.
Reagents. Recombinant pneumococcal surface protein A (PspA) was expressed in Saccharomyces cerevisiae BJ3505 as a His 6 -tagged fusion protein and purified by nickel-nitrilotriacetic acid affinity chromatography (55) . PsaA and PspC (CbpA) were expressed as N-terminal His 6 -fusion proteins in recombinant Escherichia coli cells and purified by nickel-nitrilotriacetic acid affinity chromatography, as previously described (35, 38) . The purified proteins were Ͼ95% pure as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after staining with Coomassie brilliant blue R250. Phosphorylcholine-keyhole limpet hemacyanin (PC-KLH) was synthesized as described previously (55) . The resulting conjugate had a substitution degree of 19 PC/KLH molecule. Purified S. pneumoniae capsular polysaccharide type 14 (PPS14) was purchased from the American Type Culture Collection (Manassas, Va.).
Preparation and immunization of S. pneumoniae type 14. A frozen stock of S. pneumoniae capsular type 14 (S. pneumoniae type 14) was thawed and subcultured on BBL premade blood agar plates (VWR International, Bridgeport, N.J.). Isolated colonies on blood agar were grown in Todd-Hewitt broth (Becton Dickinson, Sparks, Md.) to mid-log phase, collected, and heat killed by incubation at 60°C for 1 h. Sterility was confirmed by subculture on blood agar plates. After extensive washings, the bacterial suspension was adjusted with phosphatebuffered saline (PBS) to give an absorbance reading at 650 nm of 0.6, which corresponded to 10 9 CFU/ml. Bacteria were then aliquoted at 10 10 CFU/ml and frozen at Ϫ80°C until used as antigen for mouse immunizations. Mice were immunized intraperitoneally (i.p.) with 2 ϫ 10 8 CFU of heat-killed bacteria in 250 l of PBS. The S. pneumoniae type 14 stock was tested for endotoxin using the Limulus amebocyte lysate assay (QCL-1000) from BioWhittaker (Walkersville, Md.). This assay demonstrated that mice injected with 2 ϫ 10 8 CFU equivalents of S. pneumoniae type 14 received Ͻ20 pg of endotoxin (if at all). Serum samples for measurement of anti-PPS14, anti-PC, anti-PspA, anti-PsaA, and anti-PspC antibody titers were prepared from blood obtained through the tail vein.
Real-time reverse transcription-PCR (RT-PCR) for measurement of splenic cytokine-specific mRNA ex vivo. Total RNA was extracted from isolated spleen cell populations using RNAzol B (TEL-TEST, Inc., Friendswood, Tex.). Total RNA was then reverse transcribed using the Superscript II preamplification system for first-strand cDNA synthesis (Invitrogen) according to the manufacturer's instructions. A 180-ng aliquot of RNA was subsequently used as template for each real-time PCR. All PCRs for cytokine-specific mRNA were performed on an ABI Prism 7700 sequence detector system (PE Applied Biosystems, Foster City, Calif.) using proprietary cytokine-specific primers and probes from ABI Applied Biosystems (Rockville, Md.). Relative cytokine mRNA levels were determined by normalization of signal with that for rRNA. In initial studies, twofold dilutions of cDNA generated a linear signal curve over at least a 30-fold range of cDNA concentrations.
Measurement of cytokine concentrations in spleen cell culture supernatant (SN). The concentrations of specific cytokines released into the media of spleen cell cultures to which S. pneumoniae type 14 was added were measured using optimized standard sandwich enzyme-linked immunosorbent assay (ELISA). Recombinant cytokines used as standards, as well as the capture monoclonal antibodies, biotinylated monoclonal antibodies used for detection, and streptavidin-alkaline phosphatase (AP) were purchased from BD Pharmingen (San Diego, Calif. Measurement of serum antigen-specific Ig isotype titers. Immulon 4 ELISA plates (Dynex Technologies, Inc., Chantilly, Va.) were coated (50 l/well) with either PC-KLH (5 g/ml), PPS14 (5 g/ml), PspA (5 g/ml), PsaA (1 g/ml), or PspC (1 g/ml) in PBS for 1 h at 37°C or overnight at 4°C. Plates were washed three times with PBS plus 0.1% Tween 20 and were blocked with PBS plus 1% bovine serum albumin for 30 min at 37°C or overnight at 4°C. Threefold dilutions of serum samples, starting at a 1/50 serum dilution in PBS plus 0.05% Tween 20 were then added for 1 h at 37°C or overnight at 4°C, and plates were washed three times with PBS plus 0.1% Tween 20. AP-conjugated polyclonal goat antimouse IgM or IgG antibodies (200 ng/ml final concentration in PBS plus 0.05% Tween 20) were then added, and plates were incubated at 37°C for 1 h. Plates were washed five times with PBS plus 0.1% Tween 20. Substrate (p-nitrophenyl phosphate, disodium; Sigma) at 1 mg/ml in TM buffer (1 M Tris plus 0.3 mM MgCl 2 ; pH 9.8) was then added for 30 min at room temperature for color development. Color was read at an absorbance of 405 nm on a Multiskan Ascent ELISA reader (Labsystems). No cross-reactivity was observed between the serum titers of anti-PspA, anti-PspC, and anti-PsaA using the respective recombinant proteins in the dilution buffer, where only the relevant protein mediated blocking (data not shown). Further, addition of C-polysaccharide (10 g/ml) plus Cps22F (20 g/ml) into the serum dilution buffer did not inhibit signal generation in the IgG anti-PPS14 ELISA and inhibited Ͻ10% of the signal generated in the IgM anti-PPS14 ELISA. Sera from R36A (unencapsulated variant of type 2 S. pneumoniae)-immunized mice also did not react in the anti-PPS14 ELISA. Thus, these blocking reagents were not routinely used in this assay.
Lethality studies. Live S. pneumoniae type 14 cells were grown to mid-log phase. Bacterial numbers were determined by colony counts on blood agar (Becton Dickinson, Cockeysville, Md.). Mice were injected i.p. with either 2 ϫ 10 8 , 1 ϫ 10 8 , 4 ϫ 10 7 , and/or 2 ϫ 10 7 live S. pneumoniae type 14 in 250 l of PBS. Mice were observed daily for up to 7 days after infection.
Statistics. Data were expressed as arithmetic means Ϯ standard errors of the means (SEM) of the individual titers. Levels of significance of the differences between groups were determined by the Student t test. P values of Յ0.05 were considered statistically significant.
RESULTS
MyD88
؊/؊ mice, but not TLR2 ؊/؊ mice, are defective in splenic cytokine and chemokine induction in response to i.p. immunization with intact heat-killed S. pneumoniae type 14. We utilized mice genetically deficient in TLR2 (TLR2 Ϫ/Ϫ ) (47) to first determine the early splenic cytokine response to S. pneumoniae. We utilized heat-killed S. pneumoniae type 14 diluted in PBS, which we previously demonstrated induces peak inflammatory splenic cytokine mRNA levels between 2 and 6 h following i.p. immunization (20) . Injection of PBS alone had no effect (data not shown). TLR2
Ϫ/Ϫ and wild-type mice were immunized i.p. with heat-killed S. pneumoniae type 14, and spleens were removed from either naïve mice or from mice at either 2 or 6 h following immunization for determination of relative levels of selected inflammatory cytokine and chemokine mRNAs by real-time RT-PCR. No significant differences were observed between TLR2
Ϫ/Ϫ and wild-type mice in the relative induction of mRNA specific for IL-1, IL-6, IL-12, IFN-␥, TNF-␣, macrophage inflammatory protein 1␣ (MIP-1␣), or monocyte chemotactic protein 1 (MCP-1) at either 2 or 6 h following immunization (Fig. 1, upper panel) .
MyD88 is an adaptor protein that plays a critical role in signaling via all TLRs, as well as through the IL-1R and IL-18R, including signals required for cytokine induction (1, 19, 48) . Of note, TLR3 and TLR4 can signal immune cells in a MyD88-independent manner, utilizing another TLR adaptor designated Ticam-1 or Trif, of particular importance for induction of type 1 IFN (17, 18) . Thus, we utilized MyD88 Ϫ/Ϫ mice (1) to determine whether a TLR other than, or in addition to, TLR2 was required for in vivo cytokine induction in response to S. pneumoniae type 14. As with TLR2 Ϫ/Ϫ mice, MyD88
and wild-type mice were immunized i.p. with heat-killed S. pneumoniae type 14 and spleens were removed from either naïve mice or mice at either 2 or 6 h following immunization for real-time RT-PCR analysis. MyD88 Ϫ/Ϫ mice were markedly defective in their induction of splenic mRNA specific for IL-1, IL-12, IFN-␥, TNF-␣, MIP-1␣, and MCP-1 at both 2 and 6 h postimmunization. In notable contrast, MyD88
Ϫ/Ϫ and wild-type mice consistently exhibited equivalent induction of IL-6 mRNA in response to S. pneumoniae type 14 ( Fig. 1,  lower Ϫ/Ϫ and wild-type 129B6 mice (five per group) were immunized i.p. with heat-killed S. pneumoniae type 14 (2 ϫ 10 8 CFU/mouse). Spleens were removed from naïve (unimmunized) mice (five per group) and from mice at 2 and 6 h following immunization. RNA was purified, and real-time RT-PCR was performed to determine the relative expression levels of selected cytokine and chemokine mRNAs by using rRNA to standardize individual samples. The arithmetic mean of specific mRNA levels in spleen cells obtained from individual unimmunized mice was arbitrarily assigned a value of 1. Values represent the arithmetic mean Ϯ SEM. *, P Յ 0.05. Data are representative of two independent experiments.
various concentrations of heat-killed S. pneumoniae type 14 and measured the SN concentrations of IL-6, IL-12, TNF-␣, and IFN-␥ 24 h later by ELISA. Wild-type and TLR2 Ϫ/Ϫ spleen cells secreted equivalent amounts of all four cytokines in a dose-dependent manner and at each dose of S. pneumoniae type 14 (Fig. 2) . In contrast, MyD88
Ϫ/Ϫ spleen cells failed to secrete detectable IL-12, TNF-␣, IFN-␥, and even IL-6 at any dose of S. pneumoniae type 14. Thus, with the exception of IL-6 in MyD88 Ϫ/Ϫ mice, the changes observed in splenic cytokine mRNA and cytokine protein levels after challenge with S. pneumoniae type 14 were consistent. The potential mechanism(s) and significance underlying the differences observed between splenic IL-6 mRNA and protein are discussed below.
MyD88 ؊/؊ , but not TLR2 ؊/؊ , mice are more sensitive to killing, relative to wild-type mice, after i.p. challenge with live S. pneumoniae type 14. The early release of proinflammatory cytokines during the innate response to bacteria is important in mediating bacterial clearance prior to the onset of adaptive, humoral immunity (20) . Although TLR2 Ϫ/Ϫ mice appeared to make a largely normal splenic cytokine and chemokine response to challenge with S. pneumoniae type 14, the number of cytokines and chemokines tested were limited and only the spleen was evaluated, thus raising the possibility of mediator and/or site-selective, but critical, defects in their innate response to S. pneumoniae type 14. An analogous, though converse, argument could also be made concerning MyD88 Fig. 5 and 6, below). On day 28, immunized mice were infected i.p. with 4 ϫ 10 7 CFU of live S. pneumoniae type 14 and compared with their similarly infected naïve counterparts (eight animals per group). Neither naïve nor immunized wild-type mice were killed by S. pneumoniae type 14 over a 5-day period (Fig. 3C) . Although all of the naïve MyD88 Ϫ/Ϫ mice were killed by S. pneumoniae type 14 by day 4, none of the immunized MyD88 Ϫ/Ϫ mice succumbed to infection over a 5-day period. In contrast to naïve MyD88 Ϫ/Ϫ mice, naïve TLR2 Ϫ/Ϫ mice were found to be at most only slightly more vulnerable to killing with live S. pneumoniae type 14 than wild-type mice (Fig. 3D) (21) . Whereas the IgM anti-PC and anti-PPS14 response to S. pneumoniae type 14 is T-cell independent, induction of IgG anti-PC, anti-PPS14, and anti-PspA is dependent on CD4 ϩ T cells. Boosting of S. pneumoniae type 14-primed mice leads to substantial increases in both IgG anti-PspA as well as IgG anti-PC responses, but no further increases in IgG anti-PPS14 (21) . Further, endogenous releases of proinflammatory cytokines (e.g., TNF-␣, IL-6, and IFN-␥) are independently stimulatory for both anti-PspA and anti-PC responses (20) . In light of an earlier finding that immunization of MyD88 Ϫ/Ϫ mice with purified antigens in adjuvant leads to defective type 1, but not type 2, T-cell priming and subsequent IgG isotype production (42), we wished to determine the IgM and IgG isotype antipolysaccharide and antiprotein responses to intact S. pneumoniae type 14 in both TLR2
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice. TLR2
Ϫ/Ϫ and wild-type mice were immunized i.p. with heatkilled S. pneumoniae type 14 and similarly boosted 14 days later. Surprisingly, TLR2
Ϫ/Ϫ mice exhibited a significant reduction in type 1 IgG isotypes (i.e., IgG3, IgG2b, and IgG2a) specific for PC and PPS14 in both the primary and secondary response (Fig. 4) . More modest reductions in serum IgM anti-PC and anti-PPS14 titers in TLR2 Ϫ/Ϫ mice were observed, although not at all time points. In contrast, both TLR2 Ϫ/Ϫ and wild-type mice elicited a similar type 2, IgG1 anti-PC and anti-PPS14 response. Of note, the anti-PspA response in TLR2 Ϫ/Ϫ mice was comparable to that observed in wild-type mice for all IgG isotypes (Fig. 4) .
As further illustrated in Fig. 5 , MyD88 Ϫ/Ϫ mice, relative to wild-type mice, immunized and boosted i.p. with heat-killed S. pneumoniae type 14 also had significant decreases in type 1 IgG isotype responses (IgG3, IgG2a, and IgG2b) specific for PC and PPS14 to an extent comparable to that observed in TLR2 Ϫ/Ϫ mice. The type 2 IgG isotype (IgG1) was, in contrast, significantly higher in MyD88 Ϫ/Ϫ versus wild-type mice for both PC and PPS14, although not at all time points. Only a variably modest reduction in IgM anti-PC was observed in MyD88 Ϫ/Ϫ mice. These overall differences were observed for both the primary and secondary responses. In contrast to TLR2 Ϫ/Ϫ mice, MyD88 Ϫ/Ϫ mice showed a defective type 1, although normal type 2, IgG isotype response specific for PspA (Fig. 5) . Although the preimmune serum titers of IgM anti-PPS14 appeared to be different between control C57BL/6 and B6I29 mice, analysis of these serum samples on the same set of ELISA plates indicated equivalent preimmune titers (data not shown). Given the relative nature of serum titer calculations, sera from each experiment were analyzed using the same set of ELISA plates, allowing for the accurate, direct comparisons between different experimental groups.
In a final set of experiments, we wished to determine whether the differences observed between TLR2 Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice in the IgG anti-PspA response represented a more generalized difference in the overall antiprotein response between these two strains of mice. Thus, we further analyzed the sera from the experiments illustrated in Fig. 4 and 5 for serum IgG isotype titers specific for two additional proteins, PspC (CbpA) (pneumococcal surface protein C or cholinebinding protein A) and PsaA (pneumococcal surface antigen A). The former is bound to PC, which is linked to the cell wall C-polysaccharide (teichoic acid), whereas the latter is a membrane-bound lipoprotein. Of note, whereas strong primary IgG anti-PspA responses were typically observed in both the C57BL/6 and 129B6 wild-type mice challenged with heat-killed S. pneumoniae type 14, we observed very weak primary IgG anti-PspC and IgG anti-PsaA responses in these two wild-type strains (data not shown). However, upon boosting of primed mice with S. pneumoniae type 14, a strong induction of IgG anti-PspC and IgG anti-PsaA was obtained. In striking contrast to what we observed for IgG anti-PspA, secondary type 1, but not type 2, IgG isotype titers specific for PspC and PsaA were significantly reduced in both TLR2 Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice (Fig. 6) . Collectively, these data indicate that TLR2 plays a dominant role in the induction of type 1 humoral immunity specific for both proteins and polysaccharide antigens in response to intact, heat-killed S. pneumoniae type 14, whereas the innate response, though MyD88 dependent, can be effectively mediated through a TLR(s) other than TLR2.
DISCUSSION
TLR2 has been implicated as an important innate recognition receptor for gram-positive extracellular bacteria (36, 43, 49, 52) , and it independently plays a significant though variable role in innate protection against S. pneumoniae, possibly dependent upon the initial site of infection (11, 20, 31) . However, little is known concerning the role of TLR2, or that of the general TLR adaptor protein MyD88, in shaping in vivo antiprotein and antipolysaccharide Ig isotype responses to S. pneumoniae or other intact gram-positive extracellular bacteria. In this report we demonstrate a critical role for MyD88 in mediating innate cytokine release and early protection following i.p. injection of intact S. pneumoniae, although no apparent, independent role was observed for TLR2. However, both MyD88 Ϫ/Ϫ and TLR2 Ϫ/Ϫ mice showed substantial deficiencies in elicitation of type 1 IgG isotypes (i.e., IgG3, IgG2b, and IgG2a) specific for a number of protein and polysaccharide antigens in response to immunization with intact S. pneumoniae. A notable exception was the normal type 1 IgG antiPspA response observed in TLR2 Ϫ/Ϫ , but not MyD88 Ϫ/Ϫ , mice. In contrast, we demonstrated either normal or elevated IgG1 (type 2) antiprotein and antipolysaccharide responses in both TLR2
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice. IgM antipolysaccharide responses in TLR2 Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice were only modestly reduced. These studies leave open the additional possibility of a role for either TLR1 and/or TLR6 in regulating the TLR2-dependent induction of the S. pneumoniae type 14-induced type 1 IgG response, in light of the critical role for these former TLRs as coreceptors for certain TLR2 ligands (36, 50, 51) .
These data are the first to implicate a role for TLR2 in shaping a type 1 IgG humoral immune response to an extracellular bacterium, although the mechanism underlying this defect is currently unknown. In this regard, i.p. immunization with S. pneumoniae induces early splenic IL-12, IFN-␥, MIP-1␣, and MCP-1 mRNA expression in TLR2 Ϫ/Ϫ mice that is quantitatively similar to that in wild-type mice at both 2 and 6 h postimmunization. Secretion of both IL-12 and IFN-␥ protein from TLR2
Ϫ/Ϫ and wild-type spleen cells stimulated with S. (29, 34) . Of note, our analyses of cytokine and chemokine induction were limited to a select number of key proinflammatory cytokines and chemokines, leaving open the likely prospect that a selective defect in TLR2 Ϫ/Ϫ mice that is critical for promotion of type 1 immunity will be revealed by a more comprehensive analysis of mediator expression. We believe it unlikely that kinetic differences in mediator release underlie the defective type 1 humoral response, since we previously demonstrated that splenic cytokine mRNA expression returns to baseline by 12 h in wild-type mice and remains at baseline levels up to 3 days following immunization (20) .
Our analyses of the TLR dependence of the innate and humoral responses to i.p. challenge with S. pneumoniae involved immunization of mice with heat-killed S. pneumoniae type 14. Heat-killing of S. pneumoniae destroys pneumolysin activity, which is otherwise present in live S. pneumoniae (7) . Pneumolysin was recently shown to be a TLR4 ligand capable of stimulating IL-6 and TNF-␣ from macrophages (31) . In this regard, TLR4 Ϫ/Ϫ mice were shown to be more susceptible to lethality following intranasal colonization with pneumolysinpositive S. pneumoniae (31) . Although our lethality studies necessarily utilized live S. pneumoniae expressing pneumolysin, we believe that our logical correlations with innate cytokine production using heat-killed S. pneumoniae are still valid. Thus, TLR2
Ϫ/Ϫ mice, unlike MyD88 Ϫ/Ϫ mice, exhibited largely normal innate responses to i.p. injection of heat-killed S. pneumoniae, even in the absence of pneumolysin, suggesting other redundant, non-TLR2-dependent pathways. Further, TLR4-mediated cytokine induction, as would be observed using pneumolysin, is also MyD88 dependent, suggesting that cytokine profiles between heat-killed and live S. pneumoniae are likely to be similar in MyD88 Ϫ/Ϫ mice. A possible exception is the potential for TLR4-dependent, MyD88-independent effects, such as type 1 interferon induction (17, 18) . Our demonstration of defective type 1 humoral immunity in TLR2 Ϫ/Ϫ mice, using heat-killed S. pneumoniae, further indicates that in the absence of pneumolysin, and possibly other heat-sensitive TLR ligands, TLR2-mediated signaling alone can be critical for induction of TLR-dependent type 1 humoral immunity. However, these data leave open the possibility that an additional TLR(s) and its ligand(s) (e.g., TLR4 and pneumolysin) may play a redundant role in Ig isotype induction in response to live S. pneumoniae.
The striking differences observed in the induction of the early cytokine response in TLR2 Ϫ/Ϫ versus MyD88 Ϫ/Ϫ mice by using heat-killed S. pneumoniae type 14 implicate a TLR ligand other than TLR2 in the innate response to intact S. pneumoniae. Although heat-killing of S. pneumoniae resulted in loss of TLR4-dependent pneumolysin activity, continued expression of an additional, heat-stable TLR4 ligand, currently unappreciated, is possible. Another possibility is that unmethylated CpG-containing DNA in the S. pneumoniae genome mediates TLR9 signaling, known to be entirely MyD88 depen- (12, 25, 28) . Additionally, TLR9 Ϫ/Ϫ mice were shown to have a defective antigen-specific Th1 response in response to Candida albicans (4) . Of interest, malaria schizonts were shown to activate plasmacytoid dendritic cells via TLR9 to secrete IFN-␣. However, a schizont-soluble fraction that had this activity was heat labile and precipitated by ammonium sulfate, indicating that the active component was not DNA (37) . Recently, it was demonstrated that single-stranded RNA, especially that containing poly(G) or poly(U) and poly(G), can signal immune cells via murine TLR7 or human TLR8 (9, 15) . Of interest, single-stranded RNA from Streptococcus pyogenes and Enterococcus faecalis was able to induce IL-12 when transfected into human monocyte-derived dendritic cell precursors costimulated with CD40 ligand; eukaryotic RNA did not have this effect (24) .
Our observation that endogenous TLR2 signaling in response to heat-killed S. pneumoniae is necessary for induction of type 1 humoral immunity stands in contrast to previous studies that suggested a key role for TLR2 in elicitation of type 2 immunity (10, 39, 40) . In one study, coinjection of the TLR2 ligand Pam 3 Cys with ovalbumin (OVA) was shown to augment a type 2 response and exacerbate disease in a model of experimental asthma, whereas TLR9 signaling in response to a CpG-containing oligodeoxynucleotide promoted a type 1 response and ameliorated disease (40) . Similarly, adoptive transfer of OVA-specific transgenic CD4 ϩ T cells and OVA peptide in combination with Pam 3 CyS versus E. coli lipopolysaccharide (LPS; a TLR4 ligand) into wild-type mice followed by OVA restimulation of spleen cells in vitro resulted in induction of lower levels of IFN-␥ and higher levels of IL-4 and IL-5 when using Pam 3 CyS relative to that with E. coli LPS, the latter instead inducing a type 1 cytokine response (10) . Similar results were observed when using Porphyromonas gingivalis LPS (a TLR2 ligand) instead of Pam 3 Cys versus E. coli LPS (39) . A significant difference between these studies and our own is their use of a purified exogenous TLR2 ligand and an isolated antigen to immunize mice, whereas we used an intact pathogen likely expressing more than one TLR ligand. Thus, it is possible that in vivo TLR2 signaling in response to S. pneumoniae is modulated by signaling inputs from other TLR, as well as non-TLR innate receptors.
Intact S. pneumoniae induces a mixed type 1-type 2 cytokine and antiprotein and antipolysaccharide IgG isotype response in vivo (19) that is dependent on CD4 ϩ T cells (21, 55) . In both TLR2
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice, we observe an intact type 2 IgG response (i.e., normal or elevated levels of IgG1) specific for both protein and polysaccharide antigens. Indeed, the normal induction of specific IgG1 in MyD88 Ϫ/Ϫ mice in response to heat-killed S. pneumoniae type 14 could account for their relative resistance to subsequent killing by live S. pneumoniae type 14, relative to the response in naïve MyD88 Ϫ/Ϫ mice. Additionally, the partial induction of type I IgG isotypes in MyD88 Ϫ/Ϫ mice in response to heat-killed S. pneumoniae type 14 could also have contributed to protection. A protective effect of IgG1 against infection with live S. pneumoniae was also observed in IgG3-deficient mice immunized with an S. pneumoniae glycoconjugate (32) . Further, mouse IgG1, IgG2b, and IgG3 monoclonal antibodies, which bound to PC epitopes on pneumococcal C-polysaccharide and shared similar or identical variable regions, provided equivalent protection against infection with S. pneumoniae (5) . Of note, both TLR2 Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice exhibited a normal induction of splenic IL-6 mRNA. IL-6 has been implicated in stimulating type 2 immunity (41) . Further, IL-6 Ϫ/Ϫ mice immunized with intact S. pneumoniae have defects in both type 1 and type 2 IgG isotypes (20) . Thus, the normal IL-6 response in MyD88 Ϫ/Ϫ mice might be critical for the intact IgG1 response to S. pneumoniae. The differences observed in MyD88 Ϫ/Ϫ mice between defective in vitro induction of IL-6 protein and normal in vivo splenic IL-6-specific mRNA may reflect the engagement by S. pneumoniae of other innate receptors in vivo, not present in the in vitro culture, that can mediate cellular activation. Although a number of studies on pathogen-induced type 2 responses have indicated the existence of specific pathogen-derived inducers of type 2 differentiation (e.g., schistosome egg and filarial antigens) (30, 53) , it remains to be determined whether S. pneumoniae actively induces type 2 immunity or whether this occurs through a default pathway (14) .
FIG. 6. Both TLR2
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice have a reduced in vivo type 1 IgG anti-PspC and anti-PsaA response to heat-killed S. pneumoniae type 14 relative to wild-type controls. Serum samples were from mice described in the legends for Fig. 4 
